FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018087952> ?p ?o ?g. }

• W2018087952 endingPage "462" @default.
• W2018087952 startingPage "455" @default.
• W2018087952 abstract "Background The proportion of gram-negative causative organisms in peritoneal dialysis–associated peritonitis is increasing. Little published information for this complication exists in children. The objective of this study is to evaluate the clinical presentation, early and late response to treatment, and identification of factors influencing the outcome of gram-negative peritonitis (GNP) in children. Study Design Case series. Setting and Participants 104 children (aged 7.9 ± 5.9 years) with 121 GNP episodes reported to the International Pediatric Peritonitis Registry from October 2001 through December 2004. Predictors Patient, clinical, bacteriological, and treatment features. Outcomes Initial response to empirical treatment was assessed after approximately 72 hours of therapy. Final outcome was judged according to the occurrence of death, technique failure, relapse, need for catheter exchange, and a composite end point defining full functional recovery. Results 44% of episodes of GNP occurred in children younger than 5 years. Causative organisms included Pseudomonas species, 21%; Klebsiella species, 18%; Escherichia coli, 17%; and Acinetobacter species, 12%. Thirty-two percent of organisms classified as gram-negative were not identified further. Clinical manifestations were severe and uniform for all causative gram-negative agents. A substantial proportion (20%) of organisms were resistant to ceftazidime, with resulting suboptimal response to empirical therapy. By day 3 of initial empiric treatment, 85% of children with GNP had improved clinically (39%, complete resolution; 46%, improvement in symptoms), 10% showed poor response, and 5% had worsening of symptoms. Multivariate analysis identified severe abdominal pain, use of a single-cuff catheter, and intermittent (versus continuous) intraperitoneal ceftazidime administration as independent predictors of worse initial response to treatment. Full functional recovery was achieved in 86% of episodes. Nineteen patients (16%) required catheter removal, 11 (9%) experienced a relapse, 7 (6%) discontinued peritoneal dialysis therapy permanently, and 3 died. Lack of clinical improvement after 72 hours of therapy (odds ratio, 5.39; P < 0.01) and the presence of an exit-site infection (odds ratio, 7.69; P = 0.01) independently increased the risk of an incomplete functional recovery. Limitations The study was not designed to assess absolute incidence figures or risk factors for the development of GNP in children. Conclusions GNP is a significant complication of long-term peritoneal dialysis therapy in children, and a substantial proportion of affected children are at risk of permanent sequelae. Because results of empiric treatment with ceftazidime are suboptimal in the setting of this infection, alternative antimicrobial agents should be reconsidered. The proportion of gram-negative causative organisms in peritoneal dialysis–associated peritonitis is increasing. Little published information for this complication exists in children. The objective of this study is to evaluate the clinical presentation, early and late response to treatment, and identification of factors influencing the outcome of gram-negative peritonitis (GNP) in children. Case series. 104 children (aged 7.9 ± 5.9 years) with 121 GNP episodes reported to the International Pediatric Peritonitis Registry from October 2001 through December 2004. Patient, clinical, bacteriological, and treatment features. Initial response to empirical treatment was assessed after approximately 72 hours of therapy. Final outcome was judged according to the occurrence of death, technique failure, relapse, need for catheter exchange, and a composite end point defining full functional recovery. 44% of episodes of GNP occurred in children younger than 5 years. Causative organisms included Pseudomonas species, 21%; Klebsiella species, 18%; Escherichia coli, 17%; and Acinetobacter species, 12%. Thirty-two percent of organisms classified as gram-negative were not identified further. Clinical manifestations were severe and uniform for all causative gram-negative agents. A substantial proportion (20%) of organisms were resistant to ceftazidime, with resulting suboptimal response to empirical therapy. By day 3 of initial empiric treatment, 85% of children with GNP had improved clinically (39%, complete resolution; 46%, improvement in symptoms), 10% showed poor response, and 5% had worsening of symptoms. Multivariate analysis identified severe abdominal pain, use of a single-cuff catheter, and intermittent (versus continuous) intraperitoneal ceftazidime administration as independent predictors of worse initial response to treatment. Full functional recovery was achieved in 86% of episodes. Nineteen patients (16%) required catheter removal, 11 (9%) experienced a relapse, 7 (6%) discontinued peritoneal dialysis therapy permanently, and 3 died. Lack of clinical improvement after 72 hours of therapy (odds ratio, 5.39; P < 0.01) and the presence of an exit-site infection (odds ratio, 7.69; P = 0.01) independently increased the risk of an incomplete functional recovery. The study was not designed to assess absolute incidence figures or risk factors for the development of GNP in children. GNP is a significant complication of long-term peritoneal dialysis therapy in children, and a substantial proportion of affected children are at risk of permanent sequelae. Because results of empiric treatment with ceftazidime are suboptimal in the setting of this infection, alternative antimicrobial agents should be reconsidered." @default.
• W2018087952 created "2016-06-24" @default.
• W2018087952 creator A5010566169 @default.
• W2018087952 creator A5019792676 @default.
• W2018087952 creator A5021982943 @default.
• W2018087952 creator A5023233189 @default.
• W2018087952 creator A5026422497 @default.
• W2018087952 creator A5027825347 @default.
• W2018087952 creator A5038547566 @default.
• W2018087952 creator A5044907086 @default.
• W2018087952 creator A5048588130 @default.
• W2018087952 creator A5055351619 @default.
• W2018087952 creator A5055442551 @default.
• W2018087952 creator A5084811951 @default.
• W2018087952 creator A5086379248 @default.
• W2018087952 creator A5062729940 @default.
• W2018087952 date "2008-03-01" @default.
• W2018087952 modified "2023-10-09" @default.
• W2018087952 title "Gram-Negative Peritonitis in Children Undergoing Long-term Peritoneal Dialysis" @default.
• W2018087952 cites W1966346068 @default.
• W2018087952 cites W1979856681 @default.
• W2018087952 cites W2021693934 @default.
• W2018087952 cites W2029762500 @default.
• W2018087952 cites W2041261702 @default.
• W2018087952 cites W2045944769 @default.
• W2018087952 cites W2087766067 @default.
• W2018087952 cites W2095194047 @default.
• W2018087952 cites W2099394979 @default.
• W2018087952 cites W2117046920 @default.
• W2018087952 cites W2123665216 @default.
• W2018087952 cites W2135228630 @default.
• W2018087952 cites W2139954771 @default.
• W2018087952 cites W2149861645 @default.
• W2018087952 cites W2154338122 @default.
• W2018087952 cites W2158406109 @default.
• W2018087952 cites W2165914204 @default.
• W2018087952 cites W2168186890 @default.
• W2018087952 cites W2183837343 @default.
• W2018087952 cites W2282162923 @default.
• W2018087952 cites W2524518923 @default.
• W2018087952 cites W4302857184 @default.
• W2018087952 doi "https://doi.org/10.1053/j.ajkd.2007.11.011" @default.
• W2018087952 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18295061" @default.
• W2018087952 hasPublicationYear "2008" @default.
• W2018087952 type Work @default.
• W2018087952 sameAs 2018087952 @default.
• W2018087952 citedByCount "51" @default.
• W2018087952 countsByYear W20180879522012 @default.
• W2018087952 countsByYear W20180879522013 @default.
• W2018087952 countsByYear W20180879522014 @default.
• W2018087952 countsByYear W20180879522015 @default.
• W2018087952 countsByYear W20180879522016 @default.
• W2018087952 countsByYear W20180879522017 @default.
• W2018087952 countsByYear W20180879522018 @default.
• W2018087952 countsByYear W20180879522020 @default.
• W2018087952 countsByYear W20180879522021 @default.
• W2018087952 countsByYear W20180879522022 @default.
• W2018087952 countsByYear W20180879522023 @default.
• W2018087952 crossrefType "journal-article" @default.
• W2018087952 hasAuthorship W2018087952A5010566169 @default.
• W2018087952 hasAuthorship W2018087952A5019792676 @default.
• W2018087952 hasAuthorship W2018087952A5021982943 @default.
• W2018087952 hasAuthorship W2018087952A5023233189 @default.
• W2018087952 hasAuthorship W2018087952A5026422497 @default.
• W2018087952 hasAuthorship W2018087952A5027825347 @default.
• W2018087952 hasAuthorship W2018087952A5038547566 @default.
• W2018087952 hasAuthorship W2018087952A5044907086 @default.
• W2018087952 hasAuthorship W2018087952A5048588130 @default.
• W2018087952 hasAuthorship W2018087952A5055351619 @default.
• W2018087952 hasAuthorship W2018087952A5055442551 @default.
• W2018087952 hasAuthorship W2018087952A5062729940 @default.
• W2018087952 hasAuthorship W2018087952A5084811951 @default.
• W2018087952 hasAuthorship W2018087952A5086379248 @default.
• W2018087952 hasConcept C126322002 @default.
• W2018087952 hasConcept C141071460 @default.
• W2018087952 hasConcept C177713679 @default.
• W2018087952 hasConcept C187212893 @default.
• W2018087952 hasConcept C2779056158 @default.
• W2018087952 hasConcept C2780199535 @default.
• W2018087952 hasConcept C71924100 @default.
• W2018087952 hasConceptScore W2018087952C126322002 @default.
• W2018087952 hasConceptScore W2018087952C141071460 @default.
• W2018087952 hasConceptScore W2018087952C177713679 @default.
• W2018087952 hasConceptScore W2018087952C187212893 @default.
• W2018087952 hasConceptScore W2018087952C2779056158 @default.
• W2018087952 hasConceptScore W2018087952C2780199535 @default.
• W2018087952 hasConceptScore W2018087952C71924100 @default.
• W2018087952 hasIssue "3" @default.
• W2018087952 hasLocation W20180879521 @default.
• W2018087952 hasLocation W20180879522 @default.
• W2018087952 hasOpenAccess W2018087952 @default.
• W2018087952 hasPrimaryLocation W20180879521 @default.
• W2018087952 hasRelatedWork W2048188206 @default.
• W2018087952 hasRelatedWork W2098854885 @default.
• W2018087952 hasRelatedWork W2180833842 @default.
• W2018087952 hasRelatedWork W2204779518 @default.
• W2018087952 hasRelatedWork W2393945902 @default.
• W2018087952 hasRelatedWork W2411988209 @default.

• next